Mortality and Immune-Related Adverse Events after Immune Checkpoint Inhibitor Initiation for Cancer Among Patients with Pre-Existing Rheumatoid Arthritis: A Retrospective Comparative Cohort Study

Kaitlin R. McCarter, Taylor Wolfgang, Senada Arabelovic, Xiaosong Wang, Kazuki Yoshida, Emily Banasiak, Grace Qian, Emily Kowalski, Kathleen M.m. Vanni, Nicole R. LeBoeuf, Lydia Gedmintas, Elizabeth I. Buchbinder, Lindsey A. MacFarlane, Deepak A. Rao, Nancy A. Shadick, Ellen M. Gravallese, Jeffrey A. Sparks

BibTeX
@inproceedings{mccarter2023mortality,
  author = {Kaitlin R. McCarter and Taylor Wolfgang and Senada Arabelovic and Xiaosong Wang and Kazuki Yoshida and Emily Banasiak and Grace Qian and Emily Kowalski and Kathleen M.M. Vanni and Nicole R. LeBoeuf and Lydia Gedmintas and Elizabeth I. Buchbinder and Lindsey A. MacFarlane and Deepak A. Rao and Nancy A. Shadick and Ellen M. Gravallese and Jeffrey A. Sparks},
  title = {{Mortality and Immune-Related Adverse Events after Immune Checkpoint Inhibitor Initiation for Cancer Among Patients with Pre-Existing Rheumatoid Arthritis: A Retrospective Comparative Cohort Study}},
  booktitle = {The Lancet Rheumatology},
  year = {2023},
  doi = {10.1016/s2665-9913(23)00064-4},
}

Loading related content...

Figure